Scribd Logo
Upload

Welcome to Scribd!

  • Organovo CFO Incredible Track Record

    Uploaded by

    Unemon
    266 views3 pages
    I'd say ... quite unlucky ... when it come to PPS performance! ... CFO bio reported in the 10-K for FY 2012 "Barry D. Michaels, Chief Financial Officer and Corporate Secretary, joined us in August, 2011. Mr. Michaels was the Chief Financial Officer of Cardima, Inc., a publicly-traded medical device company (NASDAQ: CRDM), from July, 2003 through June, 2005, and thereafter a consultant to the company through January, 2008. Mr. Michaels has been an independent consultant to medical device and technology companies since 1997, and has more than 30 years of combined industry experience. Since January, 2008 and prior to joining us, Mr. Michaels devoted his time to his consulting practice. In addition to his consulting practice, Mr. Michaels served as Chief Financial Officer of Lipid Sciences (NASDAQ: LIPD), a biotechnology company, from May, 2001 through January, 2003. Prior to joining Lipid Sciences, Mr. Michaels served as the Chief Financial Officer of IntraTherapeutics, Inc., an endovascular company, from March, 2000 until its acquisition by Sulzer Medica in May, 2001. Mr. Michaels received an MBA in finance from San Diego State University and is a graduate of the Executive Program at the University of California, Los Angeles."

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    I'd say ... quite unlucky ... when it come to PPS performance! ... CFO bio reported in the 10-K for FY 2012 "Barry D. Michaels, Chief Financial Officer and Corporate Secretary, joined us in August, 2011. Mr. Michaels was the Chief Financial Officer of Cardima, Inc., a publicly-traded medical device company (NASDAQ: CRDM), from July, 2003 through June, 2005, and thereafter a consultant to the company through January, 2008. Mr. Michaels has been an independent consultant to medical device and technology companies since 1997, and has more than 30 years of combined industry experience. Since January, 2008 and prior to joining us, Mr. Michaels devoted his time to his consulting practice. In addition to his consulting practice, Mr. Michaels served as Chief Financial Officer of Lipid Sciences (NASDAQ: LIPD), a biotechnology company, from May, 2001 through January, 2003. Prior to joining Lipid Sciences, Mr. Michaels served as the Chief Financial Officer of IntraTherapeutics, Inc., an endovascular company, from March, 2000 until its acquisition by Sulzer Medica in May, 2001. Mr. Michaels received an MBA in finance from San Diego State University and is a graduate of the Executive Program at the University of California, Los Angeles."

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Flag for inappropriate content
    266 views3 pages

    Organovo CFO Incredible Track Record

    Uploaded by

    Unemon
    I'd say ... quite unlucky ... when it come to PPS performance! ... CFO bio reported in the 10-K for FY 2012 "Barry D. Michaels, Chief Financial Officer and Corporate Secretary, joined us in August, 2011. Mr. Michaels was the Chief Financial Officer of Cardima, Inc., a publicly-traded medical device company (NASDAQ: CRDM), from July, 2003 through June, 2005, and thereafter a consultant to the company through January, 2008. Mr. Michaels has been an independent consultant to medical device and technology companies since 1997, and has more than 30 years of combined industry experience. Since January, 2008 and prior to joining us, Mr. Michaels devoted his time to his consulting practice. In addition to his consulting practice, Mr. Michaels served as Chief Financial Officer of Lipid Sciences (NASDAQ: LIPD), a biotechnology company, from May, 2001 through January, 2003. Prior to joining Lipid Sciences, Mr. Michaels served as the Chief Financial Officer of IntraTherapeutics, Inc., an endovascular company, from March, 2000 until its acquisition by Sulzer Medica in May, 2001. Mr. Michaels received an MBA in finance from San Diego State University and is a graduate of the Executive Program at the University of California, Los Angeles."

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Flag for inappropriate content
    of 3

    ORGANOVO Inc. - A company with one of the Best CFOs out there.

    Just look how well performed the companies he worked for!

    Barry D. Michaels, Chief Financial Officer

    /From ONVO 2012 10K page 37 Link/ - Barry D. Michaels, Chief Financial Officer and Corporate Secretary, joined us in August, 2011. Mr. Michaels was the Chief Financial Officer of Cardima, Inc., a publicly-traded medical device company (NASDAQ: CRDM), from July, 2003 through June, 2005, and thereafter a consultant to the company through January, 2008.

    Some additional info: . Cardima Inc. Defaulted on a Loan June 2005, Cardima Inc.'s bank accounts have been frozen by its lender, which considers the heart device maker in default on a loan. All employees have been let go, the company said, adding that without an infusion of money it will be unable to continue.(Link) The company also said interim Chief Financial Officer and Secretary Barry Michaels has resigned effective immediately. (Link) Cardima was founded in 1992 and raised over $117 million in venture capital. (Link)

    Cardima Inc. was part of a suspicious PIPE Transaction December 12, 2006, the Security and Exchange Commission (Plaitiff) filed a complaint against Edwin Buchanan Lyon and his Funds (Gryphon) for having evaded the registration requirements of the federal securities laws in connection with at least thirty-five unregistered securities offerings, which are commonly referred to as "PIPEs" (Private Investments in Public Equities).

    Tpically, after agreeing to invest in a PIPE transaction, Defendants sold short the issuer's stock, frequently through "naked" short sales in Canada. Later, once the Commission declared the resale registration statement effective, Defendants used the PIPE shares to cover the short positions - a practice prohibited by the registration provisions of the federal securities laws (SEC Complaint)

    The PIPE Issuer of Transaction 24 was Cardima Inc. (August 13, 2003).

    /From ONVO 2012 10K page 37 Link/ - In addition to his consulting practice, Mr. Michaels served as Chief Financial Officer of Lipid Sciences (NASDAQ: LIPD), a biotechnology company, from May, 2001 through January, 2003.

    /From ONVO 2012 10K page 37 Link/ - Prior to joining Lipid Sciences, Mr. Michaels served as the Chief Financial Officer of IntraTherapeutics, Inc., an endovascular company, from March, 2000 until its acquisition by Sulzer Medica in May, 2001.

    Some Additional Details: January 5, 2001: Sulzer Medica paid 145m USD to acquire IntraTherapeutics, Inc., (Link1, Link2) September 1, 2002: As part of its plan to divest its cardiac and vascular divisions, Centerpulse AG /Sulzer Medica/ of Zurich has agreed to sell IntraTherapeutics to Microvena (cardiovascular medical devices; also known as ev3 Inc.) for Euro96.6mm ($95mm) (Link).

    The Transaction resulted in a 50m USD loss for Sulzer Medica (-34%)

    You might also like